1.	Phase II Study of Chloroquinoxaline Sulfonamide in Patients With Stage IV Colorectal Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: OSU-NCI-56, NCI-56, NCT00005864, 56
2.	Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 00104, P30CA033572, CHNMC-PHII-26, NCI-57, CDR0000068401, 57, NCT00008372
3.	Phase II Study of Chloroquinoxaline Sulfonamide (CQS) in Patients with Stage III/IV Nonsmall Cell Lung Cancer (Summary Last Modified 10/93) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-93050, NCI-T93-0050D, T93-0050
4.	Phase I Study of Chloroquinoxaline Sulfonamide by Continuous 7-Day Infusion for Advanced Nonhematologic Malignancies (Summary Last Modified 11/97) Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: VCC-9402, NCI-T94-0066D, T94-0066
5.	Phase I Trial of Chloroquinoxaline Sulfonamide in Patients with Solid Tumors Phase: Phase I Type: Treatment Status: Completed Age: over 18 Sponsor: NCI Protocol IDs: UMCC-8803, NCI-T88-0127C, T88-0127
6.	Phase I Study of Chloroquinoxaline Sulfonamide Chemotherapy in Adults with Refractory Solid Tumors (Summary Last Modified 07/89) Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-8860, NCI-T88-0114C, T88-0114
7.	Phase I Clinical and Pharmacologic Trial of CQS Administered Weekly to Patients with Unspecified Solid Tumors (Summary Last Modified 01/92) Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-91109, NCI-T91-0183D, T91-0183